Skip to main content

Ensysce Biosciences, Inc.

corporate_fare Company Profile

Ensysce Biosciences, Inc.

ENSC·NASDAQ·Life Sciences·CIK 0001716947

Ensysce Biosciences, Inc. is a clinical stage pharmaceutical company focused on developing innovative solutions for severe pain relief. The company aims to reduce the potential for opioid misuse, abuse, and overdose. Ensysce Biosciences is currently developing product candidates designed to improve the safety of prescription drugs. Its primary focus is on opioid pain products and opioid use disorder products. The company was originally incorporated in Delaware in April 2003 as PharmacoFore, Inc., changing its name to Signature Therapeutics Inc. in January 2012. In December 2015, Signature merged with Ensysce Biosciences, Inc. ("Former Ensysce"). In June 2021, Former Ensysce merged with Leisure Acquisition Corporation, which then changed its name to Ensysce Biosciences, Inc. The principal executive office is located at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037.

Ensysce Biosciences, Inc. (NASDAQ:ENSC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for ENSC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Formal Review of Strategic Alternatives Launched by Ensysce Biosciences
  • Cash Falls Sharply as Ensysce Biosciences Reports Widening Q1 Net Loss
  • Ensysce Biosciences Reports Widening Loss, Critical Cash Shortage, and Highly Dilutive Financing Amidst Going Concern Warning
  • Ensysce Biosciences Initiates Formal Review of Strategic Alternatives Amid Widened Loss
  • Ensysce Biosciences Secures Taiwan Patent for MPAR® Overdose Protection, Extending IP Through 2042

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.07M
Net Income
-$10.18M
Diluted EPS
-$3.98
Op. Cash Flow
-$7.81M
Free Cash Flow
-$7.93M
Operating Income
-$10.24M
Cash & Equivalents
$4.31M
Debt / Equity
0.00×
Net Margin
-200.8%
Shares Outstanding
4.57M sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013633
$0.41 +13.89% today
52-week range · as of 2026-11-18 $0.23 – $2.04
Market cap
$7M
Volume
83.4K (0.2× avg)
3-mo avg 349.7K
Live data · 2026-11-22 12:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ENSC - Filings & News (Page 2)

ENSC
May 15, 2026, 4:49 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $0.275
Real-time Price: $0.410 info
Change: +$0.135 (+49%) info
Market Cap: $7.004M info
ENSC
May 15, 2026, 4:32 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.278
Real-time Price: $0.410 info
Change: +$0.132 (+47%) info
Market Cap: $7.004M info
ENSC
May 15, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.275
Real-time Price: $0.410 info
Change: +$0.135 (+49%) info
Market Cap: $7.004M info
ENSC
May 15, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.275
Real-time Price: $0.410 info
Change: +$0.135 (+49%) info
Market Cap: $7.004M info
ENSC
May 12, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $0.329
Real-time Price: $0.410 info
Change: +$0.081 (+25%) info
Market Cap: $7.004M info
ENSC
Apr 16, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $0.5351
Real-time Price: $0.410 info
Change: -$0.1251 (-23%) info
Market Cap: $7.004M info
ENSC
Apr 08, 2026, 7:29 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $0.4889
Real-time Price: $0.410 info
Change: -$0.0789 (-16%) info
Market Cap: $7.004M info
ENSC
Apr 07, 2026, 9:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5552
Real-time Price: $0.410 info
Change: -$0.1452 (-26%) info
Market Cap: $7.004M info
ENSC
Apr 07, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $0.5475
Real-time Price: $0.410 info
Change: -$0.1375 (-25%) info
Market Cap: $7.004M info
ENSC
Apr 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.575
Real-time Price: $0.410 info
Change: -$0.165 (-29%) info
Market Cap: $7.004M info
ENSC
Mar 30, 2026, 4:50 PM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $0.5051
Real-time Price: $0.410 info
Change: -$0.0951 (-19%) info
Market Cap: $7.004M info
ENSC
Mar 27, 2026, 5:47 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5275
Real-time Price: $0.410 info
Change: -$0.1175 (-22%) info
Market Cap: $7.004M info
ENSC
Feb 27, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6451
Real-time Price: $0.410 info
Change: -$0.2351 (-36%) info
Market Cap: $7.004M info
ENSC
Jan 08, 2026, 5:14 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.410 info
Change: -$0.650 (-61%) info
Market Cap: $7.004M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets